Stocks to Watch: Many big stocks are going to be monitored in the stock market on Tuesday 17th February. Companies related to defence, railways, pharma, FMCG, infrastructure and high tech sectors have made important announcements. These stocks may see sharp movement due to big orders, joint ventures, share splits and regulatory updates.
Cochin Shipyard Ltd has been declared the L1 i.e. lowest bidder in the tender by the Defense Ministry of India to build five Next Generation Survey Vessels for the Indian Navy. The company said in its exchange filing that the estimated total value of this order is around Rs 5,000 crore. This contract will further strengthen the shipbuilding and maintenance portfolio of the company.
Texmaco Rail & Engineering Ltd has received an order worth Rs 219.18 crore from Mumbai Railways Vikas Corporation Ltd. It involves design, supply, installation, testing and commissioning of signaling equipment for the proposed Mumbai suburban line under MUTP-IIIA.
Lupine Ltd has signed a license and supply agreement with Spektus Pharma for the commercialization of the new antidepressant DeslaFlex in Canada. DeslaFlex is a new drug based on Spektus’ proprietary Flexitab oral drug delivery technology. With this partnership, Lupine will strengthen its CNS portfolio and introduce new options for the treatment of major depressive disorder.
RECPDCL, a subsidiary of Rural Electrification Corporation Ltd, has incorporated Vizag Power Transmission Ltd as a wholly owned subsidiary for the green hydrogen project. This new company has been registered on 16 February 2026. Its authorized and paid-up capital is ₹5 lakh.
TVS Supply Chain Solutions
TVS Supply Chain Solutions has signed an MoU with Italy’s ALA Group to jointly explore opportunities in India’s rapidly growing aerospace and defense supply chain market. According to the company, this market of approximately $28 billion is growing rapidly due to strong demand for complex and regulated logistics services.
BLS E-Services Limited has signed a binding term sheet to acquire 100 per cent equity stake in Atyati Technologies Private Limited. It is an all-cash deal with an equity valuation of Rs 154 crore, subject to certain conditions. The deal is expected to be completed by March 31, 2026. Provided that approval is obtained from lenders, banks, regulatory authorities and, if necessary, shareholders.
Embassy Developments Ltd has received approval from the Maharashtra Real Estate Regulatory Authority for Phase 1 of its first residential project Embassy Serenity in Alibaug, marking the company’s entry into the lifestyle and second home segment. Located in Thal Village, Alibaug, the project will develop as a resort style retreat. It will be connected to Mumbai with better road and ferry connectivity.
Reliance Consumer Products Ltd, which runs the FMCG business of Reliance Industries, has entered into a final agreement to form a majority stake joint venture with Nigeria’s Tropical General Investments Group. This step is considered an important part of the company’s global expansion strategy.
Highway Infrastructure Ltd
Highway Infrastructure Ltd has received LOA of ₹154.6 crore from NHAI on February 16 for operating the Moti Naroli fee plaza in Gujarat. The contract pertains to acting as user fee agency at Moti Naroli, Enna and Gandevi fee plazas on the eight-lane stretch of the Vadodara-Mumbai Expressway, covering multiple sections of the expressway.
Seamec Limited’s vessel Seamec Princess has been taken on charter by Supreme Offshore Construction & Technical Services Limited for SAT and air diving operations in the ONGC oilfield off the west coast of India. The estimated value of this contract is around 4.60 lakh dollars i.e. approximately Rs 4.17 crore (GST extra).
Aqylon Nexus Ltd, which works in high tech sectors like AI, space tech and semiconductor, has announced to divide its shares into 10 parts i.e. share split after the market closes. The company will convert one share of face value Rs 10 into 10 shares of face value Rs 1 and the record date for this has been fixed as March 5, 2026. The stock has risen 232 percent in the last one year
Alkem Laboratories Ltd informed that USFDA completed pre-approval inspection on 13 February 2026 at the manufacturing plant of its subsidiary Enzene Biosciences Limited in Chakan, Pune. At the end of the inspection, USFDA issued a Form 483 with six procedural observations.
Fortis Healthcare Share Price: Fortis Healthcare shares may rise by 22%, 13 analysts advise to buy
Disclaimer: The information provided here is being given for information only. It is important to mention here that investing in the market is subject to market risks. As an investor, always consult an expert before investing money. Moneycontrol never advises anyone to invest money here.